Matthew Ryan, MD

Pluvicto for Advanced Prostate Cancer

Dr. Michael Guiou, Dr. Kamal Abbi, and Dr. Matthew Ryan discuss Pluvicto, an innovative radiopharmaceutical treatment for advanced prostate cancer that delivers targeted radiation throughout the body with fewer side effects than traditional chemotherapy.

Transitioning from Pediatric to Adult Hematology-Oncology Care

Medical oncologist and hematologist Dr. Matthew Ryan and pediatric hematology/oncology social worker Emma Lehman, MSW, CAPSW, discuss the significant emotional and logistical hurdles young adults face when transitioning from the supportive, family-centered pediatric cancer care environment to the more independent adult setting.

Cancer Treatment Safety: Smarter, Not Stronger

Dr. Michael Guiou, Dr. Matthew Ryan, and Dr. Kamal Abbi discuss the key factors that impact the safety and effectiveness of cancer treatments, emphasizing the importance of patient advocacy, understanding treatment options, and working with a multidisciplinary care team.

Pluvicto for Advanced Prostate Cancer

Cancer Treatment Safety: Smarter, Not Stronger

Tumor Markers

Breaking Barriers in Hemophilia Care: The Promise of Gene Therapy

Hemophilia Treatment Advances: From Factor Replacement to Gene Therapy

Matthew Ryan, MD

Demanding Proof

The Birth of Chemotherapy

Bleeding Breakthrough